These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11772695)

  • 1. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder.
    Koran LM; Hackett E; Rubin A; Wolkow R; Robinson D
    Am J Psychiatry; 2002 Jan; 159(1):88-95. PubMed ID: 11772695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
    Davidson J; Pearlstein T; Londborg P; Brady KT; Rothbaum B; Bell J; Maddock R; Hegel MT; Farfel G
    Am J Psychiatry; 2001 Dec; 158(12):1974-81. PubMed ID: 11729012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.
    Chouinard G; Goodman W; Greist J; Jenike M; Rasmussen S; White K; Hackett E; Gaffney M; Bick PA
    Psychopharmacol Bull; 1990; 26(3):279-84. PubMed ID: 2274626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
    Mowla A; Boostani S; Dastgheib SA
    J Clin Psychopharmacol; 2016 Dec; 36(6):720-723. PubMed ID: 27811556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.
    Rasmussen S; Hackett E; DuBoff E; Greist J; Halaris A; Koran LM; Liebowitz M; Lydiard RB; McElroy S; Mendels J; O'Connor K
    Int Clin Psychopharmacol; 1997 Nov; 12(6):309-16. PubMed ID: 9547132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents.
    Alderman J; Wolkow R; Fogel IM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):117-29. PubMed ID: 16553533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder.
    Greist JH; Jefferson JW; Kobak KA; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowtiz MR; Lydiard B
    Int Clin Psychopharmacol; 1995 Jun; 10(2):57-65. PubMed ID: 7673657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.
    Kronig MH; Apter J; Asnis G; Bystritsky A; Curtis G; Ferguson J; Landbloom R; Munjack D; Riesenberg R; Robinson D; Roy-Byrne P; Phillips K; Du Pont IJ
    J Clin Psychopharmacol; 1999 Apr; 19(2):172-6. PubMed ID: 10211919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo.
    Romano S; Goodman W; Tamura R; Gonzales J
    J Clin Psychopharmacol; 2001 Feb; 21(1):46-52. PubMed ID: 11199947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
    Jenike MA; Baer L; Summergrad P; Minichiello WE; Holland A; Seymour R
    Am J Psychiatry; 1990 Jul; 147(7):923-8. PubMed ID: 2192564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD; Birkett M; Koran L; Genduso L
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder.
    Greist J; Chouinard G; DuBoff E; Halaris A; Kim SW; Koran L; Liebowitz M; Lydiard RB; Rasmussen S; White K
    Arch Gen Psychiatry; 1995 Apr; 52(4):289-95. PubMed ID: 7702445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term sertraline treatment of children and adolescents with major depressive disorder.
    Rynn M; Wagner KD; Donnelly C; Ambrosini P; Wohlberg CJ; Landau P; Yang R
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):103-16. PubMed ID: 16553532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder.
    Cook EH; Wagner KD; March JS; Biederman J; Landau P; Wolkow R; Messig M
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1175-81. PubMed ID: 11589530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.
    Wagner KD; Cook EH; Chung H; Messig M
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S53-60. PubMed ID: 12880500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
    Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults.
    Greenberg WM; Benedict MM; Doerfer J; Perrin M; Panek L; Cleveland WL; Javitt DC
    J Psychiatr Res; 2009 Mar; 43(6):664-70. PubMed ID: 19046587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline treatment of obsessive-compulsive disorder: efficacy and tolerability of a rapid titration regimen.
    Bogetto F; Albert U; Maina G
    Eur Neuropsychopharmacol; 2002 Jun; 12(3):181-6. PubMed ID: 12007668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.